Wally Renne, DMD & Founder of the MOD Institute, Appointed to VP of Clinical Strategy Desktop Health

Michael Jafar, President and CEO of Desktop Health: “Dr. Renne is an outstanding addition to the growing Desktop Health team. He brings a deep understanding of the dental industry and he aligns with our mission of providing innovative personalized healthcare products and driving clinical excellence"

Desktop Health, a healthcare business committed to developing 3D printing and biofabrication solutions for personalized medicine, today announced the appointment of Wally Renne, DMD, to Vice President of Clinical Strategy at Desktop Health. In this position, Dr. Renne will be responsible for advancing Desktop Health’s clinical strategy for 3D printing technology solutions in digital dentistry.

In this new role, Dr. Renne will design and implement clinical studies that deliver on Desktop Health’s vision and address patient needs, as well as provide strategic direction for product development, education, and downstream commercial activities. He will also spearhead and direct multiple clinical programs, while guiding the larger strategy and clinical development plan for the global dental business.

“Dr. Renne is an outstanding addition to the growing Desktop Health team. He brings a deep understanding of the dental industry and he aligns with our mission of providing innovative personalized healthcare products and driving clinical excellence,” said Michael Jafar, President and CEO of Desktop Health. “With years of experience both as an active researcher and award-winning educator, Dr. Renne knows what it takes to deliver patient success and we’re thrilled to have him join our leadership team in this critical role.”

Dr. Renne is a global educator on digital dentistry and founder of the MOD Institute (Modern Optimized Dentistry) of Charleston, S.C., where he leads all learning and innovation initiatives at the organization. He is a contributing member of MOD Aesthetics, the private practice arm of MOD. He also recently served as a Professor and Assistant Dean of Innovation and Digital Dentistry at the Medical University of South Carolina and earned several national and regional awards for his efforts both pre-clinically and clinically. An active dental researcher, he has published more than 30 studies on scan and milling accuracy using various systems. Dr. Renne also has several patents including a patent for a platform of long-term antimicrobial dental materials.

“I am thrilled to be part of an organization that is laser-focused on providing leading innovation and education to dental practitioners, while also ensuring that clinical excellence is at the core of everything we do,” said Dr. Renne. “I’m inspired by the fact that Desktop Health has ambitious goals in all areas of digital dentistry. Its track record and reputation are already delivering clinical excellence in the field of dentistry and is quickly becoming an important and valued partner by clinicians both in the U.S. and abroad.”

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.